Mitochondrial DNA quantity increases with histopathologic grade in premalignant and malignant head and neck lesions

Michael Kim, John D. Clinger, Brett G. Masayesva, Patrick K. Ha, Marianna L. Zahurak, William H. Westra, Joseph A. Califano

Research output: Contribution to journalArticle

119 Citations (Scopus)

Abstract

Purpose: Mitochondria are highly susceptible to oxidative damage. Although mitochondrial function decreases with oxidative damage, overall mitochondrial DNA (mtDNA) content increases to compensate for general mitochondrial dysfunction. We performed quantitative polymerase chain reaction for genes specific to mitochondrial and nuclear genomes to investigate relative mitochondrial abundance in a spectrum of dysplastic head and neck tesions. Experimental Design: DNA from mild, moderate, and severe dysplasias, as well as invasive tumors and normal mucosal cells, was extracted. Using quantitative polymerase chain reaction, mitochondrial to nuclear DNA ratios were determined by quantification of cytochrome c oxidase sub-unit 1 (CoxI) and β-actin genes. Results: Mean CoxI/β-actin DNA ratios for mild, moderate, and severe premalignant lesions were 0.0529, 0.0607, and 0.1021, respectively. The mean ratio for the normal mucosal cells contained in saliva was 0.0537, whereas the mean ratio for tumors was 0.1667. As a whole, our experimental model demonstrated significance (P = 0.0358). Comparisons between individual categories showed borderline significance when compared with the normal group, with P values of 0.0673, 0.0747, and 0.0824 for moderate and severe dysplasia and invasive tumor, respectively. Conclusions: Head and neck squamous cell carcinomas arise through premalignant intermediates and may be merely morphologic manifestations of accumulated genetic alterations. In keeping with this molecular tumor progression model, our study shows that mtDNA increases according to histopathologic grade, a phenomenon that may be a feedback mechanism that compensates for a generalized decline in respiratory chain function. Therefore, high mtDNA content may be another marker of genetic alteration, a measure of relative DNA Injury, and a surrogate measure of histopaihologic grade.

Original languageEnglish (US)
Pages (from-to)8512-8515
Number of pages4
JournalClinical Cancer Research
Volume10
Issue number24
DOIs
StatePublished - Dec 15 2004
Externally publishedYes

Fingerprint

Mitochondrial DNA
Neck
Head
Actins
DNA
Neoplasms
Polymerase Chain Reaction
Mitochondrial Genome
Electron Transport Complex IV
Electron Transport
Genetic Markers
Saliva
Genes
DNA Damage
Mitochondria
Research Design
Theoretical Models

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Mitochondrial DNA quantity increases with histopathologic grade in premalignant and malignant head and neck lesions. / Kim, Michael; Clinger, John D.; Masayesva, Brett G.; Ha, Patrick K.; Zahurak, Marianna L.; Westra, William H.; Califano, Joseph A.

In: Clinical Cancer Research, Vol. 10, No. 24, 15.12.2004, p. 8512-8515.

Research output: Contribution to journalArticle

Kim, Michael ; Clinger, John D. ; Masayesva, Brett G. ; Ha, Patrick K. ; Zahurak, Marianna L. ; Westra, William H. ; Califano, Joseph A. / Mitochondrial DNA quantity increases with histopathologic grade in premalignant and malignant head and neck lesions. In: Clinical Cancer Research. 2004 ; Vol. 10, No. 24. pp. 8512-8515.
@article{67225618d04f4ca28185140f6d4f8b18,
title = "Mitochondrial DNA quantity increases with histopathologic grade in premalignant and malignant head and neck lesions",
abstract = "Purpose: Mitochondria are highly susceptible to oxidative damage. Although mitochondrial function decreases with oxidative damage, overall mitochondrial DNA (mtDNA) content increases to compensate for general mitochondrial dysfunction. We performed quantitative polymerase chain reaction for genes specific to mitochondrial and nuclear genomes to investigate relative mitochondrial abundance in a spectrum of dysplastic head and neck tesions. Experimental Design: DNA from mild, moderate, and severe dysplasias, as well as invasive tumors and normal mucosal cells, was extracted. Using quantitative polymerase chain reaction, mitochondrial to nuclear DNA ratios were determined by quantification of cytochrome c oxidase sub-unit 1 (CoxI) and β-actin genes. Results: Mean CoxI/β-actin DNA ratios for mild, moderate, and severe premalignant lesions were 0.0529, 0.0607, and 0.1021, respectively. The mean ratio for the normal mucosal cells contained in saliva was 0.0537, whereas the mean ratio for tumors was 0.1667. As a whole, our experimental model demonstrated significance (P = 0.0358). Comparisons between individual categories showed borderline significance when compared with the normal group, with P values of 0.0673, 0.0747, and 0.0824 for moderate and severe dysplasia and invasive tumor, respectively. Conclusions: Head and neck squamous cell carcinomas arise through premalignant intermediates and may be merely morphologic manifestations of accumulated genetic alterations. In keeping with this molecular tumor progression model, our study shows that mtDNA increases according to histopathologic grade, a phenomenon that may be a feedback mechanism that compensates for a generalized decline in respiratory chain function. Therefore, high mtDNA content may be another marker of genetic alteration, a measure of relative DNA Injury, and a surrogate measure of histopaihologic grade.",
author = "Michael Kim and Clinger, {John D.} and Masayesva, {Brett G.} and Ha, {Patrick K.} and Zahurak, {Marianna L.} and Westra, {William H.} and Califano, {Joseph A.}",
year = "2004",
month = "12",
day = "15",
doi = "10.1158/1078-0432.CCR-04-0734",
language = "English (US)",
volume = "10",
pages = "8512--8515",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "24",

}

TY - JOUR

T1 - Mitochondrial DNA quantity increases with histopathologic grade in premalignant and malignant head and neck lesions

AU - Kim, Michael

AU - Clinger, John D.

AU - Masayesva, Brett G.

AU - Ha, Patrick K.

AU - Zahurak, Marianna L.

AU - Westra, William H.

AU - Califano, Joseph A.

PY - 2004/12/15

Y1 - 2004/12/15

N2 - Purpose: Mitochondria are highly susceptible to oxidative damage. Although mitochondrial function decreases with oxidative damage, overall mitochondrial DNA (mtDNA) content increases to compensate for general mitochondrial dysfunction. We performed quantitative polymerase chain reaction for genes specific to mitochondrial and nuclear genomes to investigate relative mitochondrial abundance in a spectrum of dysplastic head and neck tesions. Experimental Design: DNA from mild, moderate, and severe dysplasias, as well as invasive tumors and normal mucosal cells, was extracted. Using quantitative polymerase chain reaction, mitochondrial to nuclear DNA ratios were determined by quantification of cytochrome c oxidase sub-unit 1 (CoxI) and β-actin genes. Results: Mean CoxI/β-actin DNA ratios for mild, moderate, and severe premalignant lesions were 0.0529, 0.0607, and 0.1021, respectively. The mean ratio for the normal mucosal cells contained in saliva was 0.0537, whereas the mean ratio for tumors was 0.1667. As a whole, our experimental model demonstrated significance (P = 0.0358). Comparisons between individual categories showed borderline significance when compared with the normal group, with P values of 0.0673, 0.0747, and 0.0824 for moderate and severe dysplasia and invasive tumor, respectively. Conclusions: Head and neck squamous cell carcinomas arise through premalignant intermediates and may be merely morphologic manifestations of accumulated genetic alterations. In keeping with this molecular tumor progression model, our study shows that mtDNA increases according to histopathologic grade, a phenomenon that may be a feedback mechanism that compensates for a generalized decline in respiratory chain function. Therefore, high mtDNA content may be another marker of genetic alteration, a measure of relative DNA Injury, and a surrogate measure of histopaihologic grade.

AB - Purpose: Mitochondria are highly susceptible to oxidative damage. Although mitochondrial function decreases with oxidative damage, overall mitochondrial DNA (mtDNA) content increases to compensate for general mitochondrial dysfunction. We performed quantitative polymerase chain reaction for genes specific to mitochondrial and nuclear genomes to investigate relative mitochondrial abundance in a spectrum of dysplastic head and neck tesions. Experimental Design: DNA from mild, moderate, and severe dysplasias, as well as invasive tumors and normal mucosal cells, was extracted. Using quantitative polymerase chain reaction, mitochondrial to nuclear DNA ratios were determined by quantification of cytochrome c oxidase sub-unit 1 (CoxI) and β-actin genes. Results: Mean CoxI/β-actin DNA ratios for mild, moderate, and severe premalignant lesions were 0.0529, 0.0607, and 0.1021, respectively. The mean ratio for the normal mucosal cells contained in saliva was 0.0537, whereas the mean ratio for tumors was 0.1667. As a whole, our experimental model demonstrated significance (P = 0.0358). Comparisons between individual categories showed borderline significance when compared with the normal group, with P values of 0.0673, 0.0747, and 0.0824 for moderate and severe dysplasia and invasive tumor, respectively. Conclusions: Head and neck squamous cell carcinomas arise through premalignant intermediates and may be merely morphologic manifestations of accumulated genetic alterations. In keeping with this molecular tumor progression model, our study shows that mtDNA increases according to histopathologic grade, a phenomenon that may be a feedback mechanism that compensates for a generalized decline in respiratory chain function. Therefore, high mtDNA content may be another marker of genetic alteration, a measure of relative DNA Injury, and a surrogate measure of histopaihologic grade.

UR - http://www.scopus.com/inward/record.url?scp=11144222886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11144222886&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-04-0734

DO - 10.1158/1078-0432.CCR-04-0734

M3 - Article

C2 - 15623632

AN - SCOPUS:11144222886

VL - 10

SP - 8512

EP - 8515

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 24

ER -